Cinacalcet Glenmark Pharmaceuticals Europe

Cinacalcet is a medication used to manage certain conditions related to calcium and parathyroid hormone levels. This oral medication is produced by Glenmark Pharmaceuticals Europe Limited.

Cinacalcet is primarily used to treat conditions associated with elevated parathyroid hormone levels. It works by mimicking the effects of calcium on the parathyroid glands, helping to regulate hormone secretion. This medication is often prescribed for conditions like secondary hyperparathyroidism in patients with chronic kidney disease on dialysis.

Common effects of Cinacalcet may include nausea, vomiting, and dizziness. Some users might experience muscle cramps or weakness. These effects can vary from person to person and are not exhaustive.

Cinacalcet should be used with caution in patients with a history of heart disease or low blood calcium levels. It is important to follow the advice of a healthcare professional regarding its use. Always inform your healthcare provider about any other medications you are taking.

Cinacalcet may interact with certain medications, including those metabolized by the liver's cytochrome P450 enzymes. It is advisable to avoid grapefruit juice while taking this medication, as it can affect its metabolism. Always consult a healthcare professional before combining Cinacalcet with other treatments.